RFID Breast Tumor Localization System

Project Goals

Health Beacons sought to commercialize their RFID Breast Tumor Localization prototype, but needed to transform the prototype into a user-centric, tested and documented product for suitable regulatory clearances.

Sunrise Labs Solution

  • Developed prototype into a validated and verified medical device
  • Designed a more intuitive user interface
  • Obsolete components were removed and new processors, sensing coiling, and display was added
  • Responsible for testing and verification, for DHF to align with ISO-62304 and ISO-9000 processes and transfer to manufacturing

Results

Sunrise's legacy electronics experience successfully evolved the existing prototype into a commercially viable product, complete with updated electronics and a more ergonomic look and feel. This product was successfully transferred to production. It received FDA clearance in April 2017 and will be marketed and distributed by Faxitron Bioptics, LLC.
 

image description